Former Chief Executive Officer · Armata Pharmaceuticals, Inc. (ARMP)

Brian Varnum

A named executive officer of Armata Pharmaceuticals in every fiscal year CompBrief holds from FY2018 to FY2023. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2023

$634,140

Salary $331,002Stock awards $0

FY2022: $1,639,908

2nd of 5 named executive officers at Armata Pharmaceuticals by FY2023 total.

5 named officers on file for Armata Pharmaceuticals, FY2023

Brian Varnum’s pay file — $29

  • 6 fiscal years of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Armata Pharmaceuticals’s whole pay program stands against its peers

  • Armata Pharmaceuticals’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on ARMP→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 29, 2024 (DEF 14A).

Free

Get Brian Varnum’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Brian Varnum compensation by year

Armata Pharmaceuticals Summary Compensation Table · all 6 fiscal years held
In US dollars, as Armata Pharmaceuticals reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2018FY2019FY2020FY2021FY2022FY2023
Salary$320,000$320,000$398,750$463,688$525,000$331,002
Bonus$0$0$0$231,844$210,000$0
Stock awards$0$0$0$0$0$0
Option awards$0$714,556$53,504$780,403$904,908$-252,800
Non-equity incentive$128,000$89,600$159,500$0$0$0
Pension and deferred compensation$0$0$0$0$0$0
All other$0$0$0$0$0$555,938
Total$448,000$1,124,156$611,754$1,475,935$1,639,908$634,140

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Armata Pharmaceuticals, Inc. DEF 14A filed April 29, 2024, accession 0001104659-24-054149, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Armata Pharmaceuticals, Inc. filed document, accession 0001104659-24-054149. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2024.

$448K
$1.1M
$612K
$1.5M
$1.6M
$634K
FY18
FY19
FY20
FY21
FY22
FY23
SalaryBonusNon-equity incentiveOption awardsAll other

Equity holdings

unvested awards at FY2023 year-end
TypeUnvested unitsValue at year-endExercise price
Option60,000—$5.11
Option28,000—$5.14

Per the Outstanding Equity Awards at Fiscal Year-End table in Armata Pharmaceuticals, Inc.'s FY2023 proxy; value at the fiscal year-end close, as the company printed it.

Armata Pharmaceuticals’s named executive officers, FY2023

as the company reported each
Named executive officerRoleFY2023 total
Deborah BirxChief Executive Officer$1,133,931
Brian Varnum · this pageFormer Chief Executive Officer$634,140
Mina PastagiaFormer Chief Medical Officer$463,754
Erin ButlerFormer Vice President, Finance Administration$287,308
Richard RychlikFormer Vice President, Corporate Controller$197,740

The full Armata Pharmaceuticals compensation record

free company brief

This page is one person within Armata Pharmaceuticals's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Armata Pharmaceuticals's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Brian Varnum's compensation dossier · One-time report. No refunds.